Not Losing Weight on Semaglutide? Here's What's Happening

Summary: Roughly 13% of people in the STEP-1 trial did not lose 5% of body weight on semaglutide, and the cause is almost always one of eight diagnosable problems with dose, time, calories, muscle, hormones, drug interactions, sleep, or eating after appetite returns.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: about 1 in 7 people on the full 2.4 mg dose of semaglutide will not hit 5% body weight loss at 68 weeks, and that group has a name in the literature. Researchers call them "non-responders." In the STEP-1 trial that got Wegovy approved for obesity, 13.8% of participants on semaglutide did not reach the 5% threshold by week 68 ^[1]. If you are in that group, or if you are partway through and the scale has stopped moving, this is not a mystery. There is a finite list of things going wrong, and most of them are fixable.

This is a diagnostic page. Walk through the list, find the cause that matches your situation, then do the corresponding fix.

What "not losing weight" actually means on semaglutide

Before troubleshooting, set the benchmark. The STEP-1 trial enrolled 1,961 adults with a BMI of 30 or higher (or 27 with a weight-related comorbidity) and ran for 68 weeks on 2.4 mg semaglutide weekly. Mean weight loss in the medication arm was 14.9% of baseline body weight. Mean placebo loss was 2.4%. About 86% of semaglutide participants lost at least 5%, 69% lost at least 10%, and 50% lost at least 15% ^[1].

Translate that to weekly numbers. A 200-pound person on semaglutide is averaging roughly 0.4 to 0.5 pounds per week across the full 68-week study. That is the average. The first 8 to 12 weeks at low titration doses produce very little loss. Most of the curve happens between weeks 12 and 52. By month 14 to 16 the average response flattens into a plateau.

So if it is week 6, you are at 0.5 mg, and the scale is flat, you are not failing. You are on schedule. If it is week 32, you are on 2.4 mg, and the scale has not moved in two months, that is a real problem and one of the items below is the cause.

The eight diagnosable reasons

1. The dose is too low

Semaglutide is titrated up over 16 weeks: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, then 2.4 mg ^[3]. The starting doses are for tolerance, not for results. They exist so your stomach can adapt to delayed emptying without you vomiting through the first month.

Weight loss data scales with dose. In the STEP-1 trial the full 2.4 mg arm averaged 14.9% loss. Patients who stopped titrating at 1.0 mg or 1.7 mg, often because of cost, side effects, or supply, are operating on a fraction of that.

What to do: confirm you are on 2.4 mg weekly and have been for at least 12 weeks before drawing any conclusion about whether the drug "works" for you. If side effects forced you to hold at a lower dose, talk to your prescriber about extending each titration step or adding antiemetic support so you can climb the rest of the way.

2. Not enough time at the therapeutic dose

The STEP-1 average is a 68-week number. The curve is not linear. Most weight loss accumulates in months 4 through 12, after you reach 2.4 mg. People who judge the drug at week 12 because they only see 4 or 5 pounds gone are reading the curve at its slowest section.

A useful rule from the original analyses: being a responder by week 20 (defined as losing more than 5% by that mark) predicts greater than 15% total loss by week 68 in over 96% of patients. So week 20 is the first honest checkpoint. Before that, the data is too noisy to draw any conclusion.

What to do: if you started titration in the last 5 months, you have not finished the trial yet. Stay the course, weigh weekly, and assess at week 20 of being on 2.4 mg, not week 20 of starting the drug.

3. Hidden calories the appetite suppression does not catch

Semaglutide suppresses appetite. It does not change physics. If your daily intake stays at or above maintenance, the scale will not move regardless of what the drug does to your hunger.

The most common hidden categories:

• Liquid calories. Lattes, juice, smoothies, sweetened iced teas, sports drinks. A 16 oz oat milk vanilla latte from a chain coffee shop is 300 to 400 calories. Two of those a day is the entire weight loss budget gone.
• Alcohol. A glass of wine is about 125 calories, a craft beer 200 to 250, a margarita 300 to 500. Alcohol also disinhibits eating decisions, so the food calories that come with the drinks compound the problem.
• Nuts and nut butters. Calorie-dense and easy to graze, especially on a drug that has muted your typical hunger cues. Two tablespoons of peanut butter is roughly 200 calories.
• Cooking oils. A "healthy" salad dressed with three tablespoons of olive oil adds 360 calories that most people do not count.
• Bites and tastes. The handful of crackers while cooking, the fries off a kid's plate, the cheese cubes at a party. These do not feel like meals but they sum.

Semaglutide's appetite effect makes overeating harder, not impossible. If your structured meals are smaller but the in-between calories have not changed, your deficit can disappear entirely.

What to do: track every single thing you put in your mouth for two weeks. Use an app or a notebook, but be honest. Most people who think they are eating 1,500 calories are eating 2,200 once they actually count. After two weeks of honest tracking you will see the leak.

4. Not enough protein, and you are losing muscle instead of fat

The scale measures everything. It does not distinguish between fat, water, and lean tissue. On semaglutide, when caloric intake drops sharply and protein intake stays low, the body loses both fat and skeletal muscle. Muscle is denser than fat, so as it shrinks, the scale may not change much even though body composition is shifting.

Worse, low protein on a GLP-1 produces the kind of muscle loss that hurts long-term outcomes. Lower lean mass means a lower resting metabolic rate, which means the calorie deficit you started with shrinks over time. The drug "stops working" when really your body's energy use has fallen to meet your intake.

What to do: target 1.2 to 1.6 grams of protein per kilogram of body weight per day, or roughly 0.6 to 0.8 grams per pound. A 180-pound person should aim for 108 to 144 grams of protein daily. Combine that with resistance training two to three times per week. The combination protects lean mass during the loss phase and gives you a higher metabolic floor going into maintenance.

5. Hormonal problems the GLP-1 cannot fix

Semaglutide acts on appetite. It does not act on thyroid output, cortisol, or sex hormones. Untreated hormonal problems can flatten weight loss completely.

The four most common offenders:

• Hypothyroidism. Even subclinical hypothyroidism (TSH in the 4 to 10 range with normal free T4) slows resting metabolism enough to mask GLP-1 effects. Symptoms include fatigue, cold intolerance, constipation, dry skin, hair thinning. Ask for a TSH plus free T4, and if TSH is elevated, free T3 and thyroid antibodies.
• Chronic high cortisol. Cushing's syndrome is rare, but functional hypercortisolism from chronic stress, poor sleep, or alcohol is common. Symptoms include central weight gain, moon face, easy bruising, insomnia. Ask for a 24-hour urine cortisol or late-night salivary cortisol if your clinical picture fits.
• PCOS in women. Insulin resistance and elevated androgens make weight loss harder. Semaglutide still works in PCOS, but at a slower rate and often a lower total than in women without it. If you have irregular cycles, acne, hirsutism, or known PCOS, expect the curve to be flatter and stay on the drug longer.
• Perimenopause and menopause. Estrogen decline shifts fat to the abdomen and reduces resting energy expenditure. Hormone therapy is a separate conversation but worth having with a menopause-trained clinician.

What to do: ask your prescriber for a focused lab panel. At minimum: TSH, free T4, fasting glucose, HbA1c, fasting insulin, comprehensive metabolic panel, lipid panel, and for women with symptoms, a hormonal workup appropriate to your life stage.

6. Medications that fight semaglutide

Several common drug classes promote weight gain or insulin resistance, and they can blunt or fully cancel semaglutide's effect:

• Corticosteroids. Prednisone, dexamethasone, and inhaled steroids at high doses drive central fat gain and appetite. A prednisone taper for an autoimmune flare can erase a month of GLP-1 progress.
• Second-generation antipsychotics. Olanzapine, quetiapine, risperidone, clozapine. These are some of the most weight-promoting drugs in the pharmacy. If you are on one for a serious psychiatric condition, do not stop it, but recognize that your weight loss target should be adjusted and your prescriber may need to combine treatments.
• Certain antidepressants. Mirtazapine, paroxetine, and amitriptyline are the worst offenders. Bupropion is weight-neutral or favorable. SSRIs sit in the middle.
• Insulin and sulfonylureas. In type 2 diabetes care, these can drive weight gain. Many endocrinologists transition patients off sulfonylureas when starting a GLP-1.
• Beta blockers. Propranolol, metoprolol, and atenolol can modestly lower resting metabolic rate.
• Gabapentinoids. Gabapentin and pregabalin are mild weight-gain drugs at higher doses.
• Hormonal contraception. Some women retain water on combined oral contraceptives or progesterone-only methods.

What to do: list every prescription and over-the-counter drug you take. Show the list to your prescriber and ask which ones might be working against you. Sometimes there is a swap that keeps the indication treated and gets the weight obstacle out of the way. Sometimes there is not, and the dose target on semaglutide needs to be reset accordingly.

7. Sleep and stress

Less than 6 hours of sleep nightly drives ghrelin up, leptin down, and cortisol up. The result is hunger that breaks through even strong appetite suppression. People who would never reach for a midnight snack on the drug do exactly that after three nights of bad sleep.

Chronic high stress does the same thing through cortisol. Cortisol promotes visceral fat storage and insulin resistance. It also drives the kind of decision fatigue that makes people skip the workout, skip the meal prep, and order takeout.

What to do: treat sleep as part of the protocol, not a personal failing. Get 7 to 9 hours. If you cannot sleep, get a sleep study, especially if you snore or have witnessed apnea. Untreated obstructive sleep apnea is itself a barrier to weight loss because the body never gets into the deep stages where metabolic restoration happens. For stress, the interventions are not glamorous: walking outside daily, structured exercise, limiting alcohol, therapy if anxiety or depression is fueling the pattern.

8. Eating after appetite returns

This one shows up at month 9 to 14 and looks like the drug "stopped working." It usually has not. What has happened is your body adapted to the dose, the food noise crept back up, and your eating habits have quietly returned to where they were before. The drug is still producing appetite suppression relative to your baseline, but your baseline drifted.

This is the moment when many people quit semaglutide thinking it failed. In the STEP-1 extension data, people who stopped semaglutide regained about two-thirds of the lost weight within a year ^[5]. The drug works; the question is whether you have a structure in place to keep working with it.

What to do: rebuild the habits. Re-track food for a week. Re-weigh weekly. Add resistance training back if you let it slip. If you are still at 2.4 mg and genuinely cannot regain control, this is the point to talk to your prescriber about either the recently approved 7.2 mg dose of semaglutide currently in late-stage trials, or switching to tirzepatide.

Escalation: what to do next

If you have worked through the list and you are still stuck, the clinical playbook has three remaining moves.

Move 1: get labs

The minimum panel:

• TSH and free T4 (thyroid)
• HbA1c and fasting glucose (diabetes status)
• Fasting insulin (insulin resistance)
• Comprehensive metabolic panel (kidney and liver)
• Lipid panel
• Vitamin D, B12, ferritin (deficiency states that affect energy and appetite)

If your prescriber will not order these, find one who will. An obesity medicine specialist is more likely than primary care to recognize that "not losing weight" needs a workup, not a pep talk.

Move 2: confirm you are on the actual maximum dose, for long enough

The FDA-approved Wegovy maintenance dose is 2.4 mg weekly ^[3]. If you are below that and your prescriber held you there for cost or convenience, you are not on a therapeutic trial. Get to 2.4 mg, stay there 12 weeks, and reassess.

A 7.2 mg dose of semaglutide is being studied and appears to produce greater loss than 2.4 mg. It is not standard of care yet but is worth asking about if you are at 2.4 mg and need more.

Move 3: switch to tirzepatide

This is the highest-yield switch in the GLP-1 space. Tirzepatide is a dual GIP and GLP-1 receptor agonist, sold as Zepbound for weight loss and Mounjaro for type 2 diabetes. The SURMOUNT-1 trial showed mean weight loss of 20.9% at the 15 mg dose over 72 weeks, compared to semaglutide's roughly 15% in STEP-1 ^[4][1].

The head-to-head answer came in 2025. SURMOUNT-5 randomized 751 adults with obesity but without diabetes to tirzepatide or semaglutide at their highest tolerated doses for 72 weeks. Tirzepatide produced a mean 20.2% weight loss versus 13.7% for semaglutide ^[2]. About 81% of tirzepatide patients reached 10% loss compared to 60% of semaglutide patients. The non-response rate on tirzepatide was meaningfully lower.

So if you have done the work on the eight diagnosable causes, you are on 2.4 mg semaglutide, you have 12 honest weeks at that dose, and you are still under 5% loss or stuck at a plateau short of your goal, switching to tirzepatide is the evidence-supported next move. About 70% of semaglutide non-responders show meaningful loss when switched to tirzepatide in clinical settings.

What does not work

A few interventions get pitched online that the data does not support:

• Doubling up on doses. Taking 4.8 mg of semaglutide once a week instead of 2.4 mg is not a thing studied in approved trials. Side effects multiply faster than benefits.
• Going off the drug to "reset." Stopping semaglutide does not restore drug sensitivity. It restores hunger and drives regain. Roughly two-thirds of lost weight comes back within 12 months of stopping ^[5].
• Adding stimulant fat burners. The interaction profile with GLP-1s is poorly characterized and the marginal weight loss benefit is small. The risk of arrhythmia, anxiety, and elevated heart rate is real.
• Switching from injectable to "oral semaglutide" expecting better results. Oral semaglutide (Rybelsus) is approved for type 2 diabetes, not weight loss, and produces less weight reduction than the injectable form at standard doses.

Track honestly, escalate when the data says to

The honest summary is short. About 13% of semaglutide users do not respond. The rest of the people who think they are not responding are usually missing a piece of the protocol: not at full dose, not at full dose long enough, eating more than they think, losing muscle instead of fat, sitting on an untreated hormonal problem, taking a medication that fights the drug, sleeping badly, or in a quiet relapse of old eating patterns.

Run the list. Fix the one or two items that apply to you. Get labs to rule out the rest. If at 12 weeks on 2.4 mg with clean labs, honest tracking, and protein and training in place, the scale still has not moved, you have a real non-response. Talk to your prescriber about tirzepatide. The data is unambiguous about which drug produces more loss in the head-to-head trial ^[2].

Common questions

Why am I not losing weight on semaglutide after 3 months?

At 3 months you may still be in titration at 0.5 to 1 mg, which is below the therapeutic dose. Weight loss accelerates after you reach 2.4 mg and stay there for 8 to 12 weeks. Confirm your current dose before drawing conclusions.

How long should I give semaglutide before deciding it isn't working?

Twelve weeks at the maintenance 2.4 mg dose, not 12 weeks total. If you needed 16 weeks to titrate up, that means 28 weeks total before a fair assessment. Below 5% body weight loss at that point meets the clinical definition of non-response.

I lost weight on semaglutide and now I've hit a plateau. What do I do?

Plateaus typically appear around month 12 to 16 as the body adapts. Re-track food honestly, add resistance training, recheck protein intake at 1.2 to 1.6 g/kg, and rule out a hormonal change. If you have been at 2.4 mg for over 6 months at plateau, ask about switching to tirzepatide.

Can semaglutide stop working?

The drug does not lose potency. What changes is your body's adaptation: lower resting metabolic rate from any muscle loss, returning food noise, and habit drift. The fix is rebuilding the structure, not abandoning the drug.

Is Wegovy stronger than Ozempic for weight loss?

Same drug, semaglutide. Wegovy goes to 2.4 mg weekly, Ozempic typically maxes at 2.0 mg weekly. The 0.4 mg difference matters at the margins. If you are on Ozempic 2 mg and not losing, switching to Wegovy 2.4 mg is the cleanest first move.

How much weight should I lose per week on semaglutide?

About 0.4 to 0.5 pounds per week on average across 68 weeks for a 200-pound starting weight. The pace is uneven: slow in months 1 to 3, fastest in months 4 to 9, slowing again by month 12 to 14.

Will exercise speed up weight loss on semaglutide?

Yes, mainly by protecting muscle mass and improving the long-term curve. Resistance training two to three times weekly plus daily walking is the combination most studies use. Cardio alone helps less than resistance training for body composition.

Does drinking alcohol stop weight loss on semaglutide?

Alcohol adds calories, disinhibits eating, and worsens sleep. All three blunt semaglutide. Heavy drinkers see slower loss. Moderate drinkers can still lose weight if calorie intake including the alcohol stays in deficit.

Can I switch from semaglutide to tirzepatide if I'm not losing weight?

Yes, and SURMOUNT-5 data supports it. Most prescribers will switch you directly without a washout, starting at the 2.5 mg tirzepatide dose and titrating up. Many people who plateaued on semaglutide see another 5 to 10% loss on tirzepatide.

What labs should I ask for if I'm not losing weight on semaglutide?

TSH and free T4, HbA1c, fasting glucose, fasting insulin, comprehensive metabolic panel, lipid panel, vitamin D, B12, and ferritin. Add cortisol testing if symptoms suggest it and sex hormones if perimenopause or PCOS is in the picture.